Related Experiment Video
Updated: Jun 13, 2026

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance
Published on: February 17, 2023
Insulin, insulin resistance, obesity, and cancer
Emily Jane Gallagher1, Derek LeRoith
1Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA. Emily.Gallagher@mssm.edu
Abstract:
Epidemiologic studies have proposed a link between obesity, type 2 diabetes, and cancer. The pathophysiologic mechanisms involved in the development of type 2 diabetes, namely hyperinsulinemia and insulin resistance, have also been implicated in cancer development. Patients with type 2 diabetes are reported to have a worse response to cancer chemotherapy, have more complications, and have a poorer prognosis than patients with cancer without diabetes. Studies also have reported that insulin, insulin secretagogues, and metformin may have effects on tumor growth. Given the escalating worldwide prevalence of obesity and type 2 diabetes, their relationship to cancer has generated great interest and research across many fields of medicine.
Related Concept Videos
Type II Diabetes II: Pathophysiology
Psychoneuroimmunology: Diabetes and Cancer
Type II Diabetes I: Introduction
Insulin: The Receptor and Signaling Pathways
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Obesity
